• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Cramer on Mad Money now













Look at Medicis to see what they did there. Made Medicis reps interview to stay and fired 50% by keeping the best of the best from both. Cut pay by 50% and raised goals! Immediately implanted their guys into Scottsdale for 9 months calling all shots till they closed it down. Wake up. Valeant Aesthetics reps still have not received Q4 commission checks due Jan 1. You are screwed. Bend over and lube up--Mikee is coming in.